Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. 1979

A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008053 Lipid Mobilization LIPOLYSIS of stored LIPIDS in the ADIPOSE TISSUE to release FREE FATTY ACIDS. Mobilization of stored lipids is under the regulation of lipolytic signals (CATECHOLAMINES) or anti-lipolytic signals (INSULIN) via their actions on the hormone-sensitive LIPASE. This concept does not include lipid transport. Lipid Mobilizations,Mobilization, Lipid,Mobilizations, Lipid
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008892 Milk The off-white liquid secreted by the mammary glands of humans and other mammals. It contains proteins, sugar, lipids, vitamins, and minerals. Cow Milk,Cow's Milk,Milk, Cow,Milk, Cow's
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
August 1981, Metabolism: clinical and experimental,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
December 1997, Journal of lipid research,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
February 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
December 1992, Biochemical and biophysical research communications,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
November 1978, Journal of lipid research,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
January 1976, Biochimica et biophysica acta,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
December 2008, Prostaglandins, leukotrienes, and essential fatty acids,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
February 1998, Atherosclerosis,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
March 1972, Journal of lipid research,
A L Catapano, and P K Kinnunen, and W C Breckenridge, and A M Gotto, and R L Jackson, and J A Little, and L C Smith, and J T Sparrow
September 1979, FEBS letters,
Copied contents to your clipboard!